ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 113452 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 113452; 2) Community: the network communities that were significantly associated with the response to NSC 113452; 3) Molecule: the relationships between components within communities and NSC 113452; 4) MDR: the compounds that were significantly associated with the NSC 113452.

NSC Compound Enrichment Correlation
NSC 709098 Null 0.035202825328704 0.25021961
NSC 714362 Null 0.035202825328704 0.31337669
NSC 724771 Null 0.035202825328704 0.065960157
NSC 726863 6-[4-(1-cyclohexenyl)-1,3-butadiyn-1-yl]-2(2H)-pyranone 0.035202825328704 0.13987284
NSC 727759 1-benzyl-3-chloro-4-(3-chloroanilino)-2,5-dihydro-1H-2,5-pyr roledione 0.035202825328704 0.19479188
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.035202825328704 0.21472195
NSC 728319 6-(3-Homopiperazinyl1-1-propyl)-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Dihydrochloride 0.035202825328704 0.34395208
NSC 728512 1-Allyl-2-[4-chloro-5-(4-chlorophenylcarbamoyl)-2-methylthio benzenesulfonyl]-3-(5-nitro-2-furfulienimino)guanidine 0.035202825328704 0.20028196
NSC 730294 Null 0.035202825328704 0.34827912
NSC 730460 16-[4-{(3-Imidazol-1-yl)propoxy}-3-methoxybenzylidene]-3b-py rrolidino-5-androsten-17b-YL acetate 0.035202825328704 0.28585377
Total:109  Current:87    [First] [Prev] [Next] [Last]